The Art of Medical Device Reimbursement: Interview with Randel Richner, Founder of Neocure Group
This interview is a continuation of a throwback mini-series that I’ve been releasing over the past few weeks with some of my favorite Medsider guests of all time.On this particular episode, I chatted with Randel Richner, a true expert when it comes to hea
Medsider: Learn from Medtech and Healthtech Founders and CEOs
Audio is streamed directly from the publisher (media.transistor.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
This interview is a continuation of a throwback mini-series I’ve been releasing over the past few weeks with some of my favorite Medsider guests.
On this particular episode, I chatted with Randel Richner, a true expert in healthcare economics and reimbursement. At the time of this interview, she was with Neocure Group, a company she founded and later sold to Intralign. Although this discussion is several years old and the audio quality isn’t ideal, Randel's insights are timeless. Here are some of the things we covered:
- A case study of how Randel helped save a medical device company from severe reimbursement implications.
- Randel’s unique “orchestra score” philosophy and how it aids in streamlining reimbursement strategies.
- The importance of defining the difference between how hospitals get paid and how physicians get paid.
- And what Randel means by the statement “comparative effectiveness is a code word for cost-effectiveness”.